March 12, 2020 / 1:37 PM / a month ago

BRIEF-X4 Pharmaceuticals Reports Q4 Loss Per Share Of $0.66

March 12 (Reuters) - X4 Pharmaceuticals Inc:

* X4 PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* X4 HAD $128.1 MILLION IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH, AS OF DEC 31, 2019

* QTRLY LOSS PER SHARE OF $0.66

* Q4 EARNINGS PER SHARE VIEW $-0.83 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below